UnitedHealth’s Optum in lead for Riordan, Lewis & Haden-backed Avella Specialty Pharmacy

SK Capital, private equity
A pharmacist counts pills in a pharmacy in Toronto in this January 31, 2008 file photo. REUTERS/Mark Blinch/Files
UnitedHealth Group’s Optum subsidiary is nearing a deal to acquire Avella Specialty Pharmacy from Riordan, Lewis & Haden, according to sources with knowledge of the matter. The anticipated transaction comes about nine years after Riordan, Lewis & Haden acquired a ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.